Corrigendum to ‘First Use of the FloStent for Catheter-Dependent Urinary Retention Secondary to Benign Prostatic Hyperplasia: Additional Results From the RAPID I Study’ Urology 208 (2025) 17-20 | Synapse
April 20, 2026Open Access
Corrigendum to ‘First Use of the FloStent for Catheter-Dependent Urinary Retention Secondary to Benign Prostatic Hyperplasia: Additional Results From the RAPID I Study’ Urology 208 (2025) 17-20
Key Points
The aim is to correct and clarify results related to the use of FloStent for urinary issues caused by benign prostatic hyperplasia.
Correction of previously reported results
Clarification of patient outcomes
Review of intervention details
Updated findings may alter the interpretation of FloStent effectiveness
Correction acknowledges limitations in original data